Cogent Biosciences, Inc. (COGT)
NGS · Common · CUSIP 19240Q102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for COGT and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
19240Q102 (prev. 903214104 )
Market Cap
Small Cap
IPO
$12.00/share
Previous Symbol
UMRX (changed 10/2/2020)
Previous Name
Unum Therapeutics, Inc.
Business: Cogent Biosciences, Inc. is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, they are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients.

Company Contact

CEO
Andrew Robbins
CFO
John Green
Headquarters
275 Wyman Street, 3rd Floor Waltham, MA
Phone
617-945-5576
Investor Relations
Charles Wilson · 617-843-5302 · investorrelations@cogentbio.com
General Email
info@cogentbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »